Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France
- PMID: 15272223
- DOI: 10.1159/000078506
Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France
Abstract
We investigated the prevalence of multiple system atrophy (MSA) in Gironde, France, through a network of 120 public and private specialists and assessed the relationship between some environmental factors and MSA in a case-control study involving 50 MSA patients, 50 Parkinson's disease (PD) patients and 50 healthy controls. The occupational exposure to pesticides was evaluated through a job-exposure matrix. On prevalence day (November 1, 1998), the crude prevalence of MSA in Gironde was 1.94/100,000 inhabitants. We found no significant relationship between occupational exposure to pesticides and MSA. PD patients were significantly less frequently ever-smokers than controls and the same tendency was observed for MSA patients. We also described the clinical features that heralded the disease among this nonselected population.
Similar articles
-
Case-control study of multiple system atrophy.Mov Disord. 2005 Feb;20(2):158-63. doi: 10.1002/mds.20303. Mov Disord. 2005. PMID: 15382209
-
Risk factors of multiple system atrophy: a case-control study in French patients.Mov Disord. 2008 Apr 30;23(6):797-803. doi: 10.1002/mds.21857. Mov Disord. 2008. PMID: 18307243
-
Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.Mov Disord. 2010 Feb 15;25(3):341-8. doi: 10.1002/mds.22987. Mov Disord. 2010. PMID: 20108376
-
Epidemiological evidence on multiple system atrophy.J Neural Transm (Vienna). 2005 Dec;112(12):1605-12. doi: 10.1007/s00702-005-0380-7. J Neural Transm (Vienna). 2005. PMID: 16284906 Review.
-
[Multiple system atrophy].Psychol Neuropsychiatr Vieil. 2010 Sep;8(3):179-91. doi: 10.1684/pnv.2010.0212. Psychol Neuropsychiatr Vieil. 2010. PMID: 20739256 Review. French.
Cited by
-
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials.J Neurol. 2024 May;271(5):2324-2344. doi: 10.1007/s00415-024-12269-5. Epub 2024 Mar 14. J Neurol. 2024. PMID: 38483626 Free PMC article. Review.
-
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord.Front Mol Neurosci. 2021 Oct 6;14:695937. doi: 10.3389/fnmol.2021.695937. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34690692 Free PMC article. Review.
-
Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.J Mov Disord. 2012 Oct;5(2):42-7. doi: 10.14802/jmd.12010. Epub 2012 Oct 30. J Mov Disord. 2012. PMID: 24868413 Free PMC article.
-
Multiple system atrophy pathology is associated with primary Sjögren's syndrome.JCI Insight. 2020 Aug 6;5(15):e138619. doi: 10.1172/jci.insight.138619. JCI Insight. 2020. PMID: 32644976 Free PMC article.
-
Lipid dysfunction and pathogenesis of multiple system atrophy.Acta Neuropathol Commun. 2014 Feb 7;2:15. doi: 10.1186/2051-5960-2-15. Acta Neuropathol Commun. 2014. PMID: 24502382 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical